about
A novel autoantibody against fibronectin leucine-rich transmembrane protein 2 expressed on the endothelial cell surface identified by retroviral vector system in systemic lupus erythematosus.NKG2D⁺ IFN-γ⁺ CD8⁺ T cells are responsible for palladium allergyEffect of silica particle size on macrophage inflammatory responses.NK cell heparanase controls tumor invasion and immune surveillance.Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies.Activation of the NLRP3 inflammasome by cellular labile iron.Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells.Chronic lupus peritonitis is characterized by the ascites with a large content of interleukin-6.Prevalence and time course of hepatitis B virus infection in patients with systemic lupus erythematosus under immunosuppressive therapy.Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy.Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment.CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms.Aberrant erythropoiesis fuels tumor growthGeneralized laxity of connective tissue as a possible syndrome in systemic lupus erythematosusTIGIT immune checkpoint blockade restores CD8+ T-cell immunity against multiple myelomaAnticancer activity of a Gold(I) phosphine thioredoxin reductase inhibitor in multiple myelomaMyeloid immunosuppression and immune checkpoints in the tumor microenvironmentTargeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor ImmunityChemotherapy followed by anti-CD137 mAb immunotherapy improves disease control in a mouse myeloma modelUlcerative colitis is not a rare complication of Takayasu arteritisCancer-killing, decoy-resistant interleukin-18
P50
Q34322432-415DEFE8-C06E-4EE6-9ED8-12564C3201BAQ35095243-709A02F0-BC12-4E99-98EC-57D48515F367Q35134878-1873C44C-A4CD-476C-A21E-E0AEF762F49DQ38701256-035ABF95-E429-4705-988F-5CE23ADE25FDQ38708402-A893D3D1-2701-4511-9A3A-C705BD04E6E9Q38818863-CCA82D29-4A95-41BF-89FD-B279C39DDB49Q40113311-3DB77497-4169-4957-B7E1-5B2691AFE8DDQ41376388-2D7168D2-7091-4408-9823-B5A837472411Q44718415-D3986BFC-A76E-4813-8018-8C0F55B37B71Q47632566-818B6206-9778-4F53-BAC6-8B130E24E52EQ52725904-2D572C60-65F5-48C2-81CC-21521A544C31Q54212829-FAB39F0D-C599-4766-8F72-AA621AE6830EQ60489261-1569B3CA-193E-435F-AA0E-87A230195DE7Q84408550-1D136603-EA5E-4807-8F0C-5EED6FE2DAC6Q89479926-D73C164B-CCC2-4271-9F4A-F748E76FDF4BQ90078100-6BAF1412-3806-4A71-BA58-5C1DF1298BCDQ90703794-DF41710A-16CF-40A8-B420-E5DC3176DD6AQ91172466-25885CBC-EBD4-4E77-B232-0ED8D4B38B10Q92718021-EE46C1E5-7B85-4B53-BE40-F6B233F45252Q95562020-02A26275-95E1-40DA-9779-95D8B13F1867Q96341824-AB065A3B-AEAB-4835-92A6-C3A2D698ABA1
P50
description
researcher ORCID ID = 0000-0002-6631-9028
@en
wetenschapper
@nl
name
Kyohei Nakamura
@ast
Kyohei Nakamura
@en
Kyohei Nakamura
@es
Kyohei Nakamura
@nl
type
label
Kyohei Nakamura
@ast
Kyohei Nakamura
@en
Kyohei Nakamura
@es
Kyohei Nakamura
@nl
prefLabel
Kyohei Nakamura
@ast
Kyohei Nakamura
@en
Kyohei Nakamura
@es
Kyohei Nakamura
@nl
P106
P1153
17346660300
P31
P496
0000-0002-6631-9028